Unveiling the potential antibacterial action of acetylcysteine for managing Staphylococcus aureus wound infections: in vitro and in vivo study.

Summary: Treating infected wounds is a major challenge worldwide, especially when they are caused by a common germ called Staphylococcus aureus. This germ is tricky because it can build a slimy, protective shield called a "biofilm" that blocks regular antibiotics from working. Scientists decided to test a common, existing medicine called N-acetylcysteine (NC) to see if it could help. In the lab, they found that NC successfully breaks down the germ's slimy shield and stops the bacteria from growing. When they tested it on burn wounds in an animal model, NC helped the skin heal much faster, significantly lowered swelling and inflammation, and even turned on specific genes that help repair damaged skin tissue. This means NC could be a highly effective and promising new way to treat stubborn, infected wounds.